Overcoming Obstacles to Optimal Multiple Sclerosis (MS) Care in Minority Patient Populations

While multiple sclerosis (MS) disproportionately affects Whites of European descent, recent studies suggest an increasing rate among minority patient populations, including African and Hispanic Americans, compared to Caucasian Americans. Studies have shown ethnic differences in the characteristics, progression, and incidence of the disease, including greater disability at diagnosis and diagnostic delays compared to Caucasians. Because minority groups have been historically underrepresented in clinical trials, there has been a paucity of data in these populations. In this Clinical Transfers® activity, Drs. Mitzi Williams and Lilyana Amezcua will dive deeper into these topics, exploring the racial and ethnic variability in MS and disparities in care.